Brompheniramine, codeine, and phenylephrine and Mogamulizumab-kpkc Intravenous
Determining the interaction of Brompheniramine, codeine, and phenylephrine and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / codeine / phenylephrine
Brand name: M-End PE, Poly-Tussin AC, TL-Hist CD
Synonyms: n.a.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brompheniramine, codeine, and phenylephrine-Molindone
- Brompheniramine, codeine, and phenylephrine-Mometasone (Oral Inhalation)
- Brompheniramine, codeine, and phenylephrine-Mometasone and Formoterol
- Brompheniramine, codeine, and phenylephrine-Mometasone and formoterol Inhalation
- Brompheniramine, codeine, and phenylephrine-Mometasone Cream
- Brompheniramine, codeine, and phenylephrine-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Brompheniramine, Codeine, and Phenylephrine Liquid
- Mogamulizumab-kpkc Intravenous-Brompheniramine, codeine, and pseudoephedrine
- Mogamulizumab-kpkc Intravenous-Brompheniramine, dextromethorphan, and phenylephrine
- Mogamulizumab-kpkc Intravenous-Brompheniramine, dextromethorphan, and pseudoephedrine
- Mogamulizumab-kpkc Intravenous-Brompheniramine, dextromethorphan, guaifenesin, and phenylephrine
- Mogamulizumab-kpkc Intravenous-Brompheniramine, hydrocodone, and pseudoephedrine